FibroBiologics, Inc.
Data quality: 83%
FBLG
Nasdaq
Manufacturing
Chemicals
$1.37
▼
$0.03
(-2.14%)
Mkt Cap: 6.22 M
Price
$1.37
Mkt Cap
6.22 M
Day Range
$1.28 — $1.44
52-Week Range
$1.03 — $30.60
Volume
209,991
Open $1.41
50D / 200D Avg
$5.55
75.30% below
50D / 200D Avg
$8.48
83.84% below
Quick Summary
Key Takeaways
Negative free cash flow of -16.66 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-3785.99%
Below sector avg (-53.41%)
ROIC-529.82%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.78
Interest Coverage-83.25
Valuation
PE (TTM)
-0.33
Above sector avg (-1.48)
P/B Ratio49.78
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.3 | -1.5 |
| P/B | 49.8 | 1.6 |
| ROE % | -3786.0 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
ETFs Holding This Stock
BRSIX
BRSIX
0.07% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -18.65 M |
| ROE | -3785.99% | ROA | -164.64% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -16.66 M |
| ROIC | -529.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.78 |
| Interest Coverage | -83.25 | Asset Turnover | N/A |
| Working Capital | -1.48 M | Tangible Book Value | 125,000 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.33 | Forward P/E | N/A |
| P/B Ratio | 49.78 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -267.69% | ||
| Market Cap | 6.22 M | Enterprise Value | 1.36 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.42 | Revenue / Share | N/A |
| FCF / Share | -3.67 | OCF / Share | -3.61 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 89.33% |
| SBC-Adj. FCF | -19.17 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -18.65 M | -11.16 M | -16.49 M |
| EPS (Diluted) | -0.42 | -0.34 | -0.68 |
| Gross Profit | — | — | — |
| Operating Income | -16.65 M | -13.74 M | -8.89 M |
| EBITDA | — | — | — |
| R&D Expenses | 7.41 M | 4.50 M | 2.37 M |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | 200,000.0 | 20,000.0 | 147,000.0 |
| Income Tax | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 9.62 M | 16.45 M | 11.82 M |
| Total Liabilities | 3.46 M | 13.71 M | 10.57 M |
| Shareholders' Equity | 6.16 M | 2.74 M | 1.25 M |
| Total Debt | — | 300,000.0 | 60,000.0 |
| Cash & Equivalents | 4.89 M | 13.99 M | 9.16 M |
| Current Assets | 6.35 M | 14.23 M | 9.22 M |
| Current Liabilities | 1.76 M | 12.73 M | 9.18 M |
{"event":"ticker_viewed","properties":{"ticker":"FBLG","listing_kind":"stock","pathname":"/stocks/fblg","exchange":"Nasdaq","country":"US"}}